JEONG, HYUN WOO,정현우,CHO, SI YOUNG,조시영,PARK, CHAN WOONG,박찬웅,SEO, DAE BANG,서대방,KIM, WAN GI,김완기,LEE, SANG JUN,이상준
申请号：
KR1020110108904
公开号：
KR1020130044707A
申请日:
2011.10.24
申请国别(地区):
KR
年份:
2013
代理人:
摘要：
PURPOSE: A composition containing syringaresinol is provided to suppress fatty acid synthesis, to promote fatty acid oxidation, to enhance PGC 1 expression, and to prevent and treat obesity and hyperlipidemia.CONSTITUTION: A composition for preventing or treating dysbolism contains 1-80 wt% of syringaresinol as an active ingredient. Dysbolism includes disorders of carbohydrate metabolism or lipid metabolism, selected from the group consisting of obesity, type 2 diabetes, hyperlipidemia, and fatty liver. Syringaresinol is contained in extracts which is prepared using one or more selected among linseed, Phellodendron amurense Ruprecht, Acanthopanax senticosus, sesame seeds, and ginseng fruits.COPYRIGHT KIPO 2013[Reference numerals] (AA) mRNA expression of relative SIRT 1 (BB) Fat cell (CC) Liver cell (DD) Muscle cell본 발명은 시링가레시놀을 유효 성분으로 포함하는 대사 이상증 예방 또는 개선용 조성물을 개시한다.
